July 29, 2013 / 6:06 AM / 4 years ago

U.S. drugmaker Perrigo to buy Ireland's Elan for $8.6 bln

1 Min Read

DUBLIN, July 29 (Reuters) - U.S. generic drugmaker Perrigo agreed to buy Elan for $8.6 billion on Monday, ending a takeover battle over the Irish company which put itself up for sale last month.

Michigan-based Perrigo, which manufactures over-the-counter pharmaceutical products for the store brand market, will pay $6.25 per share in cash and $10.25 per share in stock, based on Friday's closing price.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below